Sigma Aldrich Signs Distribution Agreement for Molecularly Imprinted Polymers

Supelco, a division of Sigma- Aldrich, announced today that it has signed an exclusive global distribution agreement with Lund, Sweden-based MIP Technologies AB. Under the agreement, Supelco will distribute the analytical and preparative Molecularly Imprinted Polymer (MIP) separation products. The Companies will collaborate on the development of new products. MIP Technologies will continue to separately develop its process scale separations business.

These new products contain MIP particles produced by MIP Technologies. MIPs are solid phase polymer materials manufactured with specific affinity for single compounds or classes of compounds. They are applied in pharmaceutical, food & beverage and forensic markets, veterinary institutes, environmental laboratories, and health agencies where they are used in isolating trace compounds from complex matrices.

Currently available MIP products include Solid Phase Extraction (SPE) cartridges for specific analysis of chloramphenicol, tobacco nitrosamine derivatives, triazines, clenbuterol and other beta-agonists, beta-blockers, as well as beta-receptors.

The application of MIP SPE cartridges enables straightforward sample preparation for trace analysis from complex matrices like milk, meat, or urine, resulting in significantly reduced analysis time and costs, increased sensitivity, and improved detection when compared to conventional methods.

"We are very pleased to further strengthen our sample preparation product offering with the addition of this MIP SPE design," said Dave Julien, President of Sigma-Aldrich Research Specialties business unit. "In combination with our exclusive Solid Phase Micro Extraction (SPME), Flash, and classical SPE technologies, the addition of MIPs are expected to enhance Sigma-Aldrich's Supelco brand as a strong provider of innovative and unique tools for analytical sciences."

Anthony Rees, CEO of MIP Technologies, said: "This is a major step forward for our company in realizing its vision to become the number one supplier of MIP-based products. The partnership with Supelco and Sigma-Aldrich, gold standard companies in the separations arena, will create an unmatchable team in the development of selective separations materials. We are really excited by the business opportunities that this relationship will open up."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 35 countries and has 7,200 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sigma-Aldrich. (2019, March 02). Sigma Aldrich Signs Distribution Agreement for Molecularly Imprinted Polymers. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=7239.

  • MLA

    Sigma-Aldrich. "Sigma Aldrich Signs Distribution Agreement for Molecularly Imprinted Polymers". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=7239>.

  • Chicago

    Sigma-Aldrich. "Sigma Aldrich Signs Distribution Agreement for Molecularly Imprinted Polymers". AZoM. https://www.azom.com/news.aspx?newsID=7239. (accessed November 21, 2024).

  • Harvard

    Sigma-Aldrich. 2019. Sigma Aldrich Signs Distribution Agreement for Molecularly Imprinted Polymers. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=7239.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.